Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues

Ali A Rizvi; Andrej Janez; Manfredi Rizzo

doi:10.3390/ijms222212311

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues

Int J Mol Sci. 2021 Nov 15;22(22):12311. doi: 10.3390/ijms222212311.

Authors

Ali A Rizvi^{1

2}, Andrej Janez³, Manfredi Rizzo^{2

4}

Affiliations

¹ Department of Medicine, University of Central Florida College of Medicine, Orlando, FL 32827, USA.
² Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, SC 29208, USA.
³ Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Ljubljana, 1000 Ljubljana, Slovenia.
⁴ Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (Promise), School of Medicine, University of Palermo, 90100 Palermo, Italy.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) pandemic has raged for almost two years, with few signs of a sustained abatement or remission [...].

Publication types

Editorial

MeSH terms

COVID-19 / complications
COVID-19 / pathology*
COVID-19 / virology
Cardiovascular Diseases / complications*
Cardiovascular Diseases / metabolism
Cardiovascular Diseases / pathology
Diabetes Complications / pathology*
Endothelium, Vascular / metabolism
Endothelium, Vascular / physiopathology
Humans
Lipoproteins, LDL / metabolism
SARS-CoV-2 / isolation & purification

Substances

Lipoproteins, LDL